VRTX — Vertex Pharmaceuticals Incorporated | ScreenerHero

VRTXVertex Pharmaceuticals Incorporated

VIE · AT · Healthcare · Biotechnology

384.65EURMkt Cap: 97.75B EURP/E: 26.91Last update: 2026-05-12

Industry Peers

Biotechnology

103.39BDKKP/E 20.1

45.12BEURP/E 29.5

Camurus AB (publ)

30.32BSEKP/E 44.9

BioArctic AB (publ)

28.78BSEKP/E 28.2

Zealand Pharma A/S

21.93BDKKP/E 3.5

Bavarian Nordic A/S

14.40BDKKP/E 12.5

Financière de Tubize SA

8.83BEURP/E 95.3

loading…

Indicators:|

Key Statistics

Valuation

P/E (Trailing)26.91

P/E (Forward)—

PEG—

P/B—

P/S—

EV/EBITDA—

EV/Revenue—

EPS (TTM)—

EPS (Forward)—

Cash Flow & Leverage

FCF Yield—

FCF Margin—

Operating CF—

CapEx (TTM)—

Net Debt/EBITDA—

Net Debt—

Technical

SMA 50—

SMA 200—

Beta—

S&P 52W Chg—

Avg Vol (30d)0

Avg Vol (10d)—

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—

52W Range

380.8588% of range385.15

52W High385.15 EUR

52W Low380.85 EUR

Profitability

Gross Margin—

EBITDA Margin—

Profit Margin—

Oper. Margin—

ROE—

ROA—

Revenue Growth—

Earnings Growth—

Balance Sheet

Debt/Equity—

Current Ratio—

Quick Ratio—

Book Value/Sh—

Cash/Share—

Dividends

Fwd Div Rate—

Trail. Div Rate—

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Ownership

Shares Out.—

Float—

Insiders—

Institutions—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Company

Market Cap97.75B EUR

Enterprise Value—

Revenue (TTM)—

Gross Profit—

Net Income (TTM)—

Revenue/Share—

Fiscal Year End—

MR Quarter—

Employees—

Last Price384.65 EUR

CountryAT

SectorHealthcare

IndustryBiotechnology

ISIN—